Home
About
Overview
Sharing Data
ORCID
Help
History (18)
H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype.
Microcephaly, sensorineural deafness and Currarino triad with duplication-deletion of distal 7q.
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Potential nonhormonal therapeutics for medical treatment of leiomyomas.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Potential nonhormonal therapeutics for medical treatment of leiomyomas.
Potential nonhormonal therapeutics for medical treatment of leiomyomas. Semin Reprod Med. 2004 May; 22(2):121-30.
View in:
PubMed
subject areas
Female
Heparin
Humans
Interferon-alpha
Leiomyoma
ortho-Aminobenzoates
Piperidines
Pyridones
Quinazolines
Quinazolinones
Reproduction
Tetrahydronaphthalenes
Thiazolidinediones
Tocopherols
Uterine Neoplasms
authors with profiles
Ayman Al-Hendy